These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19878780)

  • 1. An open-label, single-center pilot study to determine the antifungal activity of a new nonsteroidal cream (Promiseb Topical Cream) after 7 days of use in healthy volunteers.
    Kircik L
    Clin Dermatol; 2009; 27(6 Suppl):S44-7. PubMed ID: 19878780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a nonsteroidal topical cream in a guinea pig model of Malassezia furfur infection.
    Nalamothu V; O'Leary AL; Kandavilli S; Fraser J; Pandya V
    Clin Dermatol; 2009; 27(6 Suppl):S41-3. PubMed ID: 19878779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis).
    David E; Tanuos H; Sullivan T; Yan A; Kircik LH
    J Drugs Dermatol; 2013 Apr; 12(4):448-52. PubMed ID: 23652893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent.
    Piérard GE; Ausma J; Henry F; Vroome V; Wouters L; Borgers M; Cauwenbergh G; Piérard-Franchimont C
    Dermatology; 2007; 214(2):162-9. PubMed ID: 17341867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacterium longum lysate, a new ingredient for reactive skin.
    Guéniche A; Bastien P; Ovigne JM; Kermici M; Courchay G; Chevalier V; Breton L; Castiel-Higounenc I
    Exp Dermatol; 2010 Aug; 19(8):e1-8. PubMed ID: 19624730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
    Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
    Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
    Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
    Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
    Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
    Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis.
    Wannanukul S; Chiabunkana J
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S68-71. PubMed ID: 16083165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Malassezia pachydermatis-associated seborrhoeic dermatitis in Devon Rex cats with itraconazole--a pilot study.
    Ahman S; Perrins N; Bond R
    Vet Dermatol; 2007 Jun; 18(3):171-4. PubMed ID: 17470232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical miconazole in plaque psoriasis.
    Niczyporuk W; Krajewska-Kułak E
    Rocz Akad Med Bialymst; 1997; 42(1):236-40. PubMed ID: 9581486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of once-daily versus twice-weekly terbinafine administration for the treatment of canine Malassezia dermatitis - a pilot study.
    Berger DJ; Lewis TP; Schick AE; Stone RT
    Vet Dermatol; 2012 Oct; 23(5):418-e79. PubMed ID: 22823935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability.
    Barbanoj MJ; Antonijoan R; García-Gea C; Puntes M; Gich I; Jané F
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):227-34. PubMed ID: 16082423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.